全球糖尿病监测设备市场规模、份额、趋势和成长分析报告（2026-2034年）

预计糖尿病监测设备市场将从 2025 年的 112.3 亿美元成长到 2034 年的 241.6 亿美元，2026 年至 2034 年的复合年增长率为 8.89%。

由于全球糖尿病盛行率不断上升，全球糖尿病监测设备市场正经历强劲成长。久坐不动的生活方式、不健康的饮食习惯以及日益严重的肥胖问题等因素，都导致了糖尿病患者人数的增加。糖尿病监测设备能够帮助患者定期监测血糖值，从而更好地管理病情，并降低血糖值控制不佳引发併发症的风险。

技术创新正在显着改变糖尿病监测解决方案。持续血糖监测（CGM）系统、穿戴式感测器和智慧血糖仪因其能够提供即时数据和更高的准确性而日益普及。许多最新设备还能与行动应用程式集成，使患者和医护人员能够更有效地监测血糖值趋势并调整治疗方案。

随着医疗保健系统日益重视预防医学和数位化医疗，糖尿病监测设备市场前景广阔。穿戴式健康技术和远端患者监护的广泛应用预计将推动市场成长。发展中地区医疗保健服务的改善以及非侵入性血糖监测技术的持续创新将进一步提升市场机会。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球糖尿病监测设备市场：依产品类型划分

• 市场分析、洞察与预测
• 自测血糖仪
• 连续血糖监测设备

第五章：全球糖尿病监测设备市场：依适应症划分

• 市场分析、洞察与预测
• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病

第六章 全球糖尿病监测设备市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊所
• 门诊手术中心
• 居家医疗环境
• 其他的

第七章 全球糖尿病监测设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • I-SENS Inc
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services Inc
  • Medtronic Plc
  • Dexcom Inc
  • Abbott Laboratories
  • Labiotech UG
  • ARKRAY Inc
  • Cnoga Medical Ltd
  • Sanofi SA
  • LifeScan Inc

The Diabetes Monitoring Devices Market size is expected to reach USD 24.16 Billion in 2034 from USD 11.23 Billion (2025) growing at a CAGR of 8.89% during 2026-2034.

The global diabetes monitoring devices market is experiencing strong growth due to the rising global prevalence of diabetes. Factors such as sedentary lifestyles, unhealthy diets, and increasing obesity rates are contributing to a growing diabetic population. Diabetes monitoring devices help patients track blood glucose levels regularly, enabling better disease management and reducing the risk of complications associated with uncontrolled blood sugar levels.

Technological advancements are significantly transforming diabetes monitoring solutions. Continuous glucose monitoring (CGM) systems, wearable sensors, and smart glucose meters are gaining popularity because they provide real-time data and improved accuracy. Many modern devices also integrate with mobile applications, allowing patients and healthcare providers to monitor glucose trends and adjust treatment plans more effectively.

The future of the diabetes monitoring devices market appears promising as healthcare systems emphasize preventive care and digital health integration. Increasing adoption of wearable health technologies and remote patient monitoring is expected to support market growth. Expanding healthcare access in developing regions and ongoing innovations in non-invasive glucose monitoring technologies will further strengthen market opportunities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Self-Monitoring Blood Glucose Devices
• Continuous Glucose Monitoring Devices

By Indication

• Type-I Diabetes
• Type-II Diabetes
• Gestational Diabetes

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Center
• Home Care Settings
• other

COMPANIES PROFILED

• iSENS Inc, Ascensia Diabetes Care Holdings AG, Bayer AG, F HoffmannLa Roche Ltd, Johnson Johnson Services Inc, Medtronic plc, Dexcom Inc, Abbott Laboratories, Labiotech UG, ARKRAY Inc, Cnoga Medical Ltd, Sanofi SA, LifeScan Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIABETES MONITORING DEVICES MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Self-Monitoring Blood Glucose Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Continuous Glucose Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIABETES MONITORING DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Type-I Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type-II Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Gestational Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIABETES MONITORING DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIABETES MONITORING DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Indication
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Indication
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Indication
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Indication
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Indication
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIABETES MONITORING DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 I-SENS Inc
  • 9.2.2 Ascensia Diabetes Care Holdings AG
  • 9.2.3 Bayer AG
  • 9.2.4 F. Hoffmann-La Roche Ltd
  • 9.2.5 Johnson & Johnson Services Inc
  • 9.2.6 Medtronic Plc
  • 9.2.7 Dexcom Inc
  • 9.2.8 Abbott Laboratories
  • 9.2.9 Labiotech UG
  • 9.2.10 ARKRAY Inc
  • 9.2.11 Cnoga Medical Ltd
  • 9.2.12 Sanofi S.A
  • 9.2.13 LifeScan Inc